{
  "id": 19703057,
  "title": "Rezera postpones a planned $200M IPO shortly before expected debut",
  "url": "https://urgent.news/2026/11/12/rezera-postpones-a-planned-200m-ipo-shortly-before-expected-debut",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-12T19:52:42.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/rezera-postpones-a-planned-200m-ipo-shortly-before-expected-debut/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Rezera, a biotech developing drugs for cardio and inflammatory diseases, has delayed its IPO that was scheduled for Friday, a company spokesperson confirmed to Endpoints News. The spokesperson cited “current market conditions” as the reason ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}